Prof. Dr. Nurhan Ergül
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Breast Neoplasms 11 publicationsSource: OpenAlex / PubMed MeSHView publications
- Prostatic Neoplasms 8 publications
- Hodgkin Disease 4 publications
- Urinary Bladder Neoplasms 3 publications
- Lung Neoplasms 3 publications
- Thyroid Neoplasms 2 publications
- Stomach Neoplasms 2 publications
- Adrenal Gland Neoplasms 2 publications
- Carcinoma, Squamous Cell 2 publications
- Colorectal Neoplasms 2 publications
- Bone Neoplasms 2 publications
- Neuroendocrine Tumors 2 publications
- Lymphoma, Non-Hodgkin 2 publications
- Adenocarcinoma 2 publications
- Pancreatic Neoplasms 2 publications
- Situs Inversus 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyNuclear Medicinesaglik.gov.trFrom source
- Institutionİstanbul Eğitim Araştırma Hastanesisaglik.gov.trFrom source
- Area of workBreast NeoplasmsExtracted from 11 publications · Model version —From source
- Publications86 publicationsEurope PMC, OpenAlex, ORCIDFrom source
- ORCID0000-0002-8214-9743ORCIDFrom source
- Last synchronised5 November 2026 08:56https://istanbuleah.saglik.gov.tr/TR-1039814/doktorlar.html#nurhan-ergulsaglik.gov.tr
Scientific work
Publications on Breast Neoplasms
-
Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer
Clinical nuclear medicine, 2026
DOI 10.1097/rlu.0000000000006582 PMID 42305081 Open-access full textSource: Europe PMC
-
Comparative Performance of 68Ga-FAPI-04 and 18F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis
World Journal of Nuclear Medicine, 2026
DOI 10.1055/s-0046-1819631 PMID 42077575 Open-access full textSource: OpenAlex
-
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?
Cancers, 2025
DOI 10.3390/cancers17183088 PMID 41008930 2 citations (OpenAlex) Open-access full textSource: OpenAlex
-
18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings of Polycystic Kidney-derived Paraganglioma
Molecular imaging and radionuclide therapy, 2024
DOI 10.4274/mirt.galenos.2024.03264 PMID 39373189 Open-access full textSource: Europe PMC
-
Does Radioactive Iodine Treatment Damage the Lacrimal System?
Clinical nuclear medicine, 2024
DOI 10.1097/rlu.0000000000005147 PMID 38451916 Source: ORCID
-
Contribution of 68Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005064 PMID 38271254 18 citations (OpenAlex) Source: OpenAlex
-
The Contribution of 68Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005394 PMID 39086038 18 citations (OpenAlex) Source: OpenAlex
-
Dual 177Lu–Prostate-Specific Membrane Antigen and 177Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005131 PMID 38409763 4 citations (OpenAlex) Source: OpenAlex
-
68Ga-DOTA-FAPI-46 PET/CT Imaging for Restaging in a Patient With Metastatic Pheochromocytoma
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005481 PMID 39365092 3 citations (OpenAlex) Source: OpenAlex
-
Physiological Gallbladder Accumulation on 68Ga-FAPI-46 PET/CT
Clinical Nuclear Medicine, 2024
DOI 10.1097/rlu.0000000000005480 PMID 39466623 2 citations (OpenAlex) Source: OpenAlex